Access to new medications to treat schizophrenia

Journal of Behavioral Health Services and Research

Volumn 29, Issue 1, 2002, Pages 15-29

  Mark, T ^a   Dirani, R ^a   Russo, P ^a  

^a MEDSTAT GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; DEMOGRAPHY; DRUG APPROVAL; DRUG COST; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT;

ADULT; AFRICAN AMERICANS; ANTIPSYCHOTIC AGENTS; DECISION MAKING; DRUG COSTS; DRUG UTILIZATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HUMANS; INSURANCE COVERAGE; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; UNITED STATES;

EID: 0036181532     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3015(11)70430-2     Document Type: Article

References (45)

1. Atypical antipsychotics part I: Pharmacology, pharmacokinetics, and efficacy
2. Recent advances in the pharmacotherapy of schizophrenia
3. An expert consensus guideline series: Treatment of schizophrenia 1999
4. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study
5. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic
6. A study of general practitioners' reasons for changing their prescribing behavior
7. How physicians choose drugs
8. The interaction among the criteria physicians use when prescribing
9. Information sources and clinical decisions
10. Information sources that influence physiatrists' adoption of new clinical practices
11. The role of commercial sources in the adoption of a new drug
12. Physicians' behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary
13. Physicians and the pharmaceutical industry. Is a gift ever just a gift?
14. Patterns of preference for information sources in the adoption of new drugs by specialists
15. Externalties in hospitals' and physicians' adoption of new surgical technology: An exploratory analysis
16. The state of the art versus the state of the science
17. Prescribers' beliefs and values as predictors of drug choices
18. Physician beliefs, attitudes, and prescribing behavior for antiinflammatory drugs
19. The adoption of new drugs by doctors practicing in group and solo practice
20. Rational prescribing and interpractitioner variation
21. The rate of adoption of new procedures among physicians
22. Implications of generalists' slow adoption of zidovudine in clinical practice
23. Identification and characterization of early and late prescribers in general practice
24. Clinical issues in the pharmacotherapy of African Americans
25. Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services
26. Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey
27. Treatment selection under Medicaid managed care: The case of depression
28. Prospective, naturalistic outcomes measurement: The Schizophrenia Care and Assessment Program
29. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
30. The Montgomery-Asberg Depression Scale: Reliability and validity
31. Evaluation of drug-related movement disorders in the aged
32. The behavior of maximum likelihood estimates under nonstandard conditions
33. Using least squares to approximate unknown regression functions
34. The effects of race on diagnosis and disposition from a psychiatric emergency service
35. Race and tardive dyskinesia among outpatients at a CMHC
36. Identifying risk factors for tardive dyskinsia among chronic outpatients maintained on neuroleptic medications: Results of the Yale tardive dyskinesia study
37. Nonbiological issues affecting psychopharmacological therapy: Cultural considerations
38. Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients
39. Ethnicity and antipsychotic response
40. The effect of race and sex on physicians' recommendations for cardiac catheterization